Article Sidebar
Published:
Mar 7, 2013Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Anti-diarrhea and anti-oxidant properties of Magnolol
Abstract
Methods: The effects of magnolol on castor oil-induced diarrhea, small intestinal transit (SIT) in mice were investigated. Additionally, the antioxidant activity of magnolol was assessed in mice by the following parameters: glutathione (GSH), total antioxidant capacity (T-AOC), antioxidant enzyme activities and their gene expression level.
Results: Compared with diarrhea model control group, magnolol (25, 50, or 100 mg/kg body weight) showed significant (p < 0.05) inhibitory activity against castor oil-induced diarrhea in mice. Administration of magnolol (25, 50, and 100 mg/kg) also lowered neostigmine-induced SIT acceleration to 60.34 ± 5.17, 59.61 ± 7.66, and 54.12 ± 7.27 %, respectively, as against 70.1 ± 6.89 % for neostigmine control group. In vivo antioxidant assay results showed that mice treated with magnolol
exhibited significantly (p < 0.001) higher activities of catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) activities in blood, compared to control. Similarly, magnolol proups
showed significantly higher CAT and SOD and T-AOC activities (p < 0.01) than control in liver tissues. The 100 mg/kg magnolol group had significantly higher liver GSH content than normal control group
(1.01 vs. 0.79 mg/mg protein). At 25 and 50 mg/kg doses, magnolol significantly enhanced gene expression levels of CAT (p < 0.01) in liver.
Conclusion: Findings from this study indicate that magnolol possesses anti-diarrheal activity and is probably one of the main anti-diarrhea ingredients of Cortex Magnoliae Officinalis. Magnolol modulation of the activity and gene expression of antioxidant enzymes may therefore exert beneficial effects in antioxidant defense.
Keywords: Magnolol, Diarrhea, Small intestinal transit, Antioxidant enzyme, Gene expression
